211 related articles for article (PubMed ID: 33597997)
1. Impact of percutaneous patent foramen ovale closure on migraine headaches in patients with history of ischemic neurological events.
Przemysław W; Spisak-Borowska K; Bochenek T; Konarska-Kuszewska E; Machowski J; Trusz-Gluza M; Bajor G; Mizia-Stec K; Giblett JP; Calvert PA
Postepy Kardiol Interwencyjnej; 2020 Sep; 16(3):315-320. PubMed ID: 33597997
[TBL] [Abstract][Full Text] [Related]
2. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.
Yoon JH; Kim JS; Lee DH; Shim EJ; Lee SY; Min KS; Cho DJ; Lee HR
Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter Closure of Patent Foramen Ovale: A Single Center Experience.
Milev I; Zafirovska P; Zimbakov Z; Idrizi S; Ampova-Sokolov V; Gorgieva E; Ilievska L; Tosheski G; Hristov N; Georgievska-Ismail L; Anguseva T; Mitrev Z
Open Access Maced J Med Sci; 2016 Dec; 4(4):613-618. PubMed ID: 28028400
[TBL] [Abstract][Full Text] [Related]
4. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after percutaneous patent foramen ovale closure.
Nagpal SV; Lerakis S; Flueckiger PB; Halista M; Willis P; Block PC; Douglas JS; Morris DC; Liff DA; Stewart J; Devireddy C; Veledar E; Nahab FB; Babaliaros VC
Am J Med Sci; 2013 Sep; 346(3):181-6. PubMed ID: 23328836
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience.
Araszkiewicz A; Grygier M; Iwańczyk S; Trojnarska O; Lesiak M; Grajek S
Postepy Kardiol Interwencyjnej; 2016; 12(1):49-54. PubMed ID: 26966449
[TBL] [Abstract][Full Text] [Related]
7. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial.
Mattle HP; Evers S; Hildick-Smith D; Becker WJ; Baumgartner H; Chataway J; Gawel M; Göbel H; Heinze A; Horlick E; Malik I; Ray S; Zermansky A; Findling O; Windecker S; Meier B
Eur Heart J; 2016 Jul; 37(26):2029-36. PubMed ID: 26908949
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes and Quality of Life after Patent Foramen Ovale (PFO) Closure in Patients with Stroke/Transient Ischemic Attack of Undetermined Cause and Other PFO-Associated Clinical Conditions: A Single-Center Experience.
Evola S; Camarda EA; Triolo OF; Adorno D; D'Agostino A; Novo G; Onorato EM
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762729
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Asmarats L; Côté M; Rodés-Cabau J
J Am Coll Cardiol; 2019 Jan; 73(3):278-287. PubMed ID: 30678757
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
Mazzucco S; Li L; Rothwell PM
JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255
[TBL] [Abstract][Full Text] [Related]
14. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
15. Changes in cerebral autoregulation, stroke-related blood biomarkers, and autonomic regulation after patent foramen ovale closure in severe migraine patients.
Guo ZN; Qu Y; Gao Y; Xing Y; Ma H; Liu J; Guo YZ; Chang J; Zhang P; Jin H; Sun X; Han K; Hu HH; He Q; Simpson DM; Yang Y
CNS Neurosci Ther; 2023 Oct; 29(10):3031-3042. PubMed ID: 37157233
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous patent foramen ovale closure: the Paradoxical Cerebral Embolism Prevention Registry.
Paiva L; Dinis P; Providência R; Costa M; Margalho S; Goncalves L
Rev Port Cardiol; 2015 Mar; 34(3):151-7. PubMed ID: 25727752
[TBL] [Abstract][Full Text] [Related]
17. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study.
Qi Y; Zhang Y; Luo X; Cheng G; Du Y; Liu R; Xie H; Cheng Y; Guo Y; Luo G
J Investig Med; 2021 Jan; 69(1):7-12. PubMed ID: 32928904
[TBL] [Abstract][Full Text] [Related]
19. Impaired endothelial function in patients with cryptogenic stroke and patent foramen ovale is not affected by closure.
Lantz M; Kostulas K; Settergren M; Sjöstrand C
J Interv Cardiol; 2017 Jun; 30(3):242-248. PubMed ID: 28439982
[TBL] [Abstract][Full Text] [Related]
20. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.
Furlan AJ; Reisman M; Massaro J; Mauri L; Adams H; Albers GW; Felberg R; Herrmann H; Kar S; Landzberg M; Raizner A; Wechsler L;
Stroke; 2010 Dec; 41(12):2872-83. PubMed ID: 21051670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
